Mirjam Christ-Crain – New approaches in the differential diagnosis of Diabetes insipidus

European Journal of Endocrinology Award Lecture, ECE 2019


Watch Award Lecture ›

B·R·A·H·M·S Copeptin proAVP. Early and Safe Rule-out of Acute Myocardial Infarction (AMI)

Combining the markers Copeptin and Troponin allows a safe and rapid rule-out of myocardial infarction at presentation. The efficacy and safety of this strategy has been proven in the BIC-8 prospective, randomized multicenter study.

Safe and early rule-out of Myocardial Infarction on admission with Copeptin

We now know that we can discharge patients to home with a double-normal measurement of Troponin and Copeptin due to this safety, earlier than with the standard procedure. This procedure is effective and safe." Prof. Evangelos Giannitsis, Heidelberg

Early Rule-out of Acute Myocardial Infarction with Copeptin – Professor Martin Möckel Interview

„Thanks to the Copeptin biomarker, clinics can better manage overcrowded Emergency Departments ... We have implemented a new algorithm using Copeptin and Troponin at the ED at the Charité now that our study has been published“ Principal investigator of the Biomarkers in Cardiology (BIC)-8 interventional study Prof. Martin Möckel

Early Rule-out of Acute Myocardial Infarction with Copeptin – An Interview with Bertil Lindahl

interview with Bertil Lindahl, Uppsala Clinical Research Centre, Uppsala University, Sweden